Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,250 | 1 | 71.5% |
| Education | $1,026 | 2 | 14.0% |
| Food and Beverage | $575.29 | 8 | 7.8% |
| Travel and Lodging | $490.56 | 2 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $5,755 | 4 | $0 (2019) |
| Intuitive Surgical, Inc. | $1,125 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $216.50 | 2 | $0 (2024) |
| TESARO, Inc. | $125.00 | 1 | $0 (2017) |
| Clovis Oncology, Inc. | $82.56 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $20.12 | 1 | $0 (2020) |
| Puma Biotechnology, Inc. | $17.33 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.00 | 1 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2022 | $1,125 | 3 | Intuitive Surgical, Inc. ($1,125) |
| 2020 | $37.45 | 2 | SANOFI-AVENTIS U.S. LLC ($20.12) |
| 2019 | $5,929 | 6 | Boston Scientific Corporation ($5,755) |
| 2017 | $125.00 | 1 | TESARO, Inc. ($125.00) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 08/23/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $99.61 | General |
| Category: SURGERY | ||||||
| 08/23/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $25.63 | General |
| Category: SURGERY | ||||||
| 07/12/2022 | Intuitive Surgical, Inc. | DAVINCI XI (Device) | Education | In-kind items and services | $1,000.00 | General |
| Category: SURGERY | ||||||
| 05/06/2020 | SANOFI-AVENTIS U.S. LLC | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Oncology | ||||||
| 04/29/2020 | Puma Biotechnology, Inc. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $91.50 | General |
| 08/15/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $82.56 | General |
| Category: Oncology | ||||||
| 03/27/2019 | Boston Scientific Corporation | GENERAL UTERINE TISSUE REMOVAL (Device) | Consulting Fee | Cash or cash equivalent | $5,250.00 | General |
| Category: UTERINE TISSUE REMOVAL | ||||||
| 03/27/2019 | Boston Scientific Corporation | GENERAL UTERINE TISSUE REMOVAL (Device) | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| Category: UTERINE TISSUE REMOVAL | ||||||
| 03/27/2019 | Boston Scientific Corporation | GENERAL UTERINE TISSUE REMOVAL (Device) | Food and Beverage | Cash or cash equivalent | $14.17 | General |
| Category: UTERINE TISSUE REMOVAL | ||||||
| 02/25/2019 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Travel and Lodging | In-kind items and services | $430.56 | General |
| Category: GENERAL THERAPIES | ||||||
| 04/27/2017 | TESARO, Inc. | VARUBI (Drug), ZEJULA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 84 | 159 | $57,837 | $18,723 |
| 2022 | 4 | 85 | 165 | $59,175 | $19,170 |
| 2021 | 4 | 109 | 206 | $74,104 | $25,080 |
| 2020 | 3 | 86 | 171 | $55,407 | $16,485 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 52 | $22,776 | $7,637 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 72 | $22,464 | $7,158 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $7,735 | $2,344 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 22 | $4,862 | $1,583 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 63 | $26,460 | $8,627 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 69 | $21,528 | $6,909 | 32.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $6,545 | $2,024 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 22 | $4,642 | $1,609 | 34.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 98 | $30,576 | $10,730 | 35.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 32 | 68 | $28,560 | $9,712 | 34.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $10,115 | $3,141 | 31.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 23 | $4,853 | $1,497 | 30.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 120 | $35,640 | $10,760 | 30.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 26 | 26 | $14,742 | $4,325 | 29.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 25 | $5,025 | $1,400 | 27.9% |
About Dr. Charles Drescher, MD
Dr. Charles Drescher, MD is a Specialist healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710939855.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Drescher, MD has received a total of $7,341 in payments from pharmaceutical and medical device companies, with $125.00 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($5,250).
As a Medicare-enrolled provider, Drescher has provided services to 364 Medicare beneficiaries, totaling 701 services with total Medicare billing of $79,458. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Seattle, WA
- Active Since 05/17/2006
- Last Updated 05/11/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1710939855
Products in Payments
- GENERAL UTERINE TISSUE REMOVAL (Device) $5,324
- DAVINCI XI (Device) $1,000
- GENERAL THERAPIES (Device) $430.56
- Da Vinci Surgical System (Device) $125.24
- LYNPARZA (Drug) $125.00
- VARUBI (Drug) $125.00
- Rubraca (Drug) $82.56
- JEVTANA (Drug) $20.12
- NERLYNX (Drug) $17.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Seattle
Dan Veljovich, Md, MD
Specialist — Payments: $849,617
Dr. Stephen Monteith, Md, MD
Specialist — Payments: $135,900
Allen Gown, Md, MD
Specialist — Payments: $120,116
Harry Hwang, M.d, M.D
Specialist — Payments: $94,029
Dr. Diana Hausman, M.d, M.D
Specialist — Payments: $72,000
Dr. Nancy Klein, M.d, M.D
Specialist — Payments: $47,798